INTRODUCTION!

26!
Shoulder pain is highly prevalent and among musculoskeletal disorders, it is the third 27! most common reason for visiting a primary care physician. 17, 35, 47 As many as two thirds of 28! people who have shoulder complaints receive a diagnosis of rotator cuff (RC) tendinopathy. 47 
29!
RC tendinopathy often leads to decreased function, 36 lower health-related quality of life, 36 poor 30! sleep quality, 48 and work absenteeism. 41 RC tendinopathy is a broad diagnosis and mounting 31! evidence suggest that diagnoses such as shoulder impingement syndrome, RC 32! tendinitis/tendinosis, as well as subacromial bursitis may be considered as the same clinical 33! entity. 20 
34!
Conservative treatment of RC tendinopathy generally includes rest, non-steroidal anti-35! inflammatory drugs, and rehabilitation interventions such as exercise. 20 High level evidence 36! supports exercise as an effective treatment. 21 In conjunction with exercise, physiotherapists often 37! add manual therapy (MT) interventions to address impairments potentially associated with RC 38! tendinopathy. 51 MT interventions have been defined by the International Federation of 39! Orthopaedic Manipulative Physical Therapist (IFOMPT) as skilled hand movements performed 40! by a therapist. 27 
41!
Systematic reviews on the efficacy of MT and exercises for the treatment of RC 42! tendinopathy have recently been published 7, 8 with the authors concluding that there is a lack of 43! evidence concerning the efficacy of MT when used alone and that evidence regarding the 44! efficacy of the addition of MT to exercise for the treatment of RC tendinopathy was 45! inconclusive. 7, 8 However, in these reviews, only qualitative synthesis of results was performed 46! without pooling of results into meta-analyses. Moreover, many relevant clinical trials were 47! excluded from these reviews 1, 3, 5, 11, 13, 39, 45, 49 and, since the publication of these reviews, new 48! 
METHODS
52!
Literature search
65!
Articles were included if they met the following inclusion criteria: participants were diagnosed 66! with RC tendinopathy/tendinitis, shoulder impingement syndrome, or subacromial bursitis; 67! participants were adults; a MT intervention was compared with another type of treatment 68! including other MT interventions; the study design was a randomized controlled trial (RCT); the 69! article was published in English or French (FIGURE 1). MT interventions that were considered 70! for inclusion had to be specific hands-on interventions. 27 Included interventions meeting this 71! definition were joint mobilisations, manipulations, specific soft tissue massage techniques, 72! neurodynamic interventions, and mobilizations with movement (MWM) of the shoulder girdle or 73! spine. All types of outcome measures were considered for inclusion. Studies that included 74! participants with shoulder pain without further diagnostic information were included for review 75! if it was possible to determine that the majority of participants had RC tendinopathy. Studies 76! were excluded if participants had RC full-thickness tear, calcific tendinopathy, or presented with 77! a postsurgical condition. 78!
79!
Data extraction 80!
Data and results from the included studies were extracted using a standardized form that 81! documented: characteristics of the participants, diagnostic criteria, interventions, follow-up 82! period, outcome measures, and results (TABLES 1-3). When results were missing or not fully 83! reported, efforts were made to contact the contributing authors to retrieve missing data.
84! 85!
Risk of bias appraisal tool 86!
The internal validity of the included studies was assessed with the Cochrane Risk of Bias Tool. 25 
87!
This tool appraises 5 different biases (selection, performance, attrition, detection, reporting) 88! using 8 different domains (methodological items). A score on a 3-point scale was attributed to 89! each judgement of risk of bias, (0 for a high risk of bias, 1 for an unclear risk of bias, and 2 for a 90! low risk of bias), thus a maximum of 16 points was possible if the study presented a low risk of 91! bias. Two reviewers independently assessed the risk of bias of each study and met to compare 92! 
110!
Mean differences (MD) or standardised mean differences (SMD) with 95% confidence intervals 111! (CI) were calculated using Review Manager (version 5.2) . 25 Because the overall number of 112! studies included in the meta-analyses was small and true effect sizes varied between studies, 113! random effects models were used. Alpha level was set at 0.05 to test for overall effect. Funnel 114! plots were not generated because of the small number of trials included in each meta-analysis.
25
RESULTS
117!
From the 32 potentially relevant articles identified after title and abstract review, 21 studies met 118! the eligibility criteria following full text review (FIGURE 1). 1-6, 11-13, 23, 28-30, 37, 39, 43-45, 49, 53, 54 119! 120!
Risk of bias appraisal 121!
The mean ± standard deviation (SD) score on the Cochrane Risk of Bias Tool across all studies 122! was 52.7% ± 17.0. Five studies 5, 13, 29, 30, 49 had a score of at least 69% (11/16), indicating a 123! moderate to low risk of bias. The other 16 studies 1-4, 6, 11, 12, 23, 28, 37, 39, 43-45, 53, 54 scored less than 124! 69%, indicating a high risk of bias. Reviewers' agreement on the overall risk of bias score was 125! excellent with an intraclass correlation coefficient of 0.93 (95% CI: 0.84, 0.97). Pre-consensus 126! interrater agreement for individual items of the Cochrane Risk of Bias tool ranged from fair to 127! perfect ( = 0.49, 1.0). 33 Consensus was always achieved between the pair of initial reviewers. 128!
129!
None of the studies had a low risk of bias for all the 8 methodological items. Due to the nature of 130! the intervention, blinding of the participant was rarely possible and it was achieved for only 6 of 131! the studies. 5, 13, 28, 29, 39, 49 Blinding of the provider was also impossible because of the nature of 132! the intervention. Blinding of assessors was adequately reported in 11 studies. 2, 5, 12, 13, 23, 29, 30, 37, 45, 
133!
49, 54 Risk of reporting bias was present in 18 of the 21 studies because no protocol or trial 134! registration number was provided (FIGURES 2 and 3). 135!
136!
Outcome measures 137!
Fourteen studies 1-3, 5, 6, 11, 12, 29, 30, 37, 39, 43-45 used a visual analog scale (VAS) or a numeric pain 138! rating scale (NPRS) to measure a variety of pain related outcomes. Nine trials 4, 5, 11, 23, 28-30, 43, 45 used validated functional outcome measures. Shoulder active range of motion (ROM) in flexion 140! or abduction was also commonly used as an outcome measure. 1, 3, 6, 11-13, 23, 29, 37, 43-45, 49 Seven 141! studies did not report treatment effect estimates, only reporting conclusions of statistical testing 142! or results in a graphical form. 1, 2, 6, 11, 12, 44, 53 Efforts made to contact contributing authors to 143! obtain additional results were all unsuccessful. 144!
145!
Primary analyses 146!
Overall efficacy of manual therapy compared with a placebo or in addition to another 147! intervention Thirteen RCTs assessed the effect of MT compared to a sham treatment or assessed 148! the effect of adding a MT intervention to another intervention such as: exercises, electrotherapy, 149! or education. 1, 2, 4, 6, 12, 29, 30, 37, 39, [43] [44] [45] 49 Eleven RCTs 1, 2, 6, 12, 29, 30, 37, 39, [43] [44] [45] assessed treatment 150! effect using pain as an outcome measure and 5 trials used functional changes. 2, 4, 29, 30, 45 Ten 1, 2, 6, 12, 29, 30, 37, 39, 43, 45 of the 11 RCTs (n=406) provided results and were pooled to evaluate the 152! efficacy of MT on pain relief. Pooled results demonstrated a significant effect in favor of the MT 153! intervention either when used alone or when used in conjunction with another intervention (10 154! cm VAS MD: 1.1; 95% CI: 0.6, 1.6); this effect is small but could be considered clinically 155! important (FIGURE 4). 46 
151!
156! 157!
For the 5 RCTs (n=206) using functional outcome measures, pooling of the results was 158! attempted but significant heterogeneity was present ( 2 P<.00001 and I 2 =93%). Therefore, the 159! results from these trials are presented in the following sections depending on the MT intervention 160! under study and comparators. 2, 4, 29, 30, 45 
Secondary analyses 163!
MT alone compared with a placebo Four clinical trials assessed the efficacy of MT compared 164! with a placebo to address pain. 1, 37, 39, 45 Interventions consisted of shoulder girdle and cervical 165! spine mobilization and manipulations. Results of these 4 trials (n=195) were pooled into a meta-166! analysis and revealed a significant effect in favor of MT (10 cm VAS MD: 1.0; 95% CI: 0.6, 1.4) 167! (FIGURE 5). 54 At 2 to 3 years, there were no differences between 239! groups in terms of symptoms, functional limitations, and perception of being cured.
53
240!
Another RCT compared supraspinatus deep friction massage to therapeutic ultrasound. pain was also performed. Seven studies 1, 2, 11, 29, 30, 37, 39 in which interventions were only joint 278! (capsular) mobilisations or manipulations (n=329) compared with a placebo or in addition to 279! another intervention were pooled into a meta-analysis. The resulting pooled effect showed a 280! significant difference in favor of MT (10 cm VAS MD: 0.7; 95%CI: 0.2, 1.2) but this effect may 281! not be clinically important (FIGURE 8). 46 Significant heterogeneity prevented us from pooling 282! clinical trials using other types of MT interventions ( 2 P<.10 and I 2 >60%). 283!
284!
Effect of adding a thoracic manipulation to MT and exercises
285!
One exploratory trial not included in any of the current meta-analyses, that included only 9 286! participants assessed the efficacy of adding a thoracic spinal manipulation to active and passive 287! glenohumeral joint mobilizations, transverse frictions to the RC tendons, and shoulder 288! strengthening exercises. 28 No statistical analyses were performed within and between groups, but 289! the thoracic manipulation group tended to require fewer sessions to feel cured. 
DISCUSSION
291!
The aim of this systematic review was to assess the efficacy of MT for RC tendinopathy.
292!
Twenty-one RCTs were included, with risk of bias established as high to moderate. 293!
294!
Primary findings 295!
Based on our primary meta-analysis of 10 RCTs, there is low to moderate evidence, that overall, 296! MT either alone or in conjunction with other modalities, may be effective in reducing pain.
297!
While pooled results demonstrate a statistically significant difference of 1.1 (95%CI: 0.6, 1.6) on 298! a 10 cm scale, the point estimate is slightly below the previously reported minimal clinically 299! important difference (MCID) of 1.4 cm. 46 However, this MCID is within the 95% CI and 300! therefore we can not exclude the possibility that MT may have a clinically important therapeutic 301! effect. 46 It is also important to highlight that this MCID has been defined for change occurring 302! after 6 weeks of treatment and this does not reflect the exact time period when outcomes were 303! measured in the studies included in our meta-analysis.
304! 305!
Secondary findings 306!
Secondary analyses include research designs that separate out the effects attributable to manual 307! therapy, which provides evidence of efficacy. Conclusions from those secondary analyses were 308! consistent with those of our primary analysis and lead to similar conclusions. Compared with a 309! placebo, MT alone significantly reduces overall pain. Similar to the results of the primary 310! analysis, while the point estimate of the pooled treatment effect is slightly below the MCID, the 311! MCID is within the limits of the 95% CI of the treatment effect.
46 Therefore we cannot rule out 312! the possibility that although the treatment effect is small, it may be clinically important. 
314!
One study with moderate risk of bias concluded that MT significantly increases function as 315! measured with the CMS compared with placebo; however, the difference between the groups 316! was small (mean ± SD: 2.0% ± 12) and not considered clinically important. 45 Two trials assessed 317! the effect of MT compared with a placebo for changes in shoulder ROM with only 1 of the trials 318! presenting a significant difference favoring MT, but again the differences were small (3° to 7°); a 319! third trial assessed pain free shoulder ROM and found a significant difference favoring the MT 320! group which could be clinically important.
1, 45, 49 Therefore, it is unclear whether or not MT 321! results in greater improvement in ROM when compared with a placebo, but it seems that it could 322! however be superior to improve pain-free ROM.
323! 324!
There is low evidence that adding MT to an exercise program could improve pain but may not 325! lead to any additional improvement in function. Results from 7 trials 2, 6, 12, 29, 30, 43, 44 of low to 326! moderate quality in which 5 were pooled into a meta-analysis 2, 6, 29, 30, 43 suggest a statistically 327! significant decrease in pain that could be considered clinically important.
46 From a qualitative 328! analysis of 6 low to moderate quality RCTs that assessed functional changes, a positive trend in 329! functional improvement was observed. Results from 4 of the 6 RCTs reported a significant 330! difference in favor of MT but again for 3 of these RCTs the magnitude of the treatment effect 331! was generally small and it is unclear if the magnitude of change is clinically important. Because 332! in these studies, the results were only partially reported or the functional outcome measures used 333! were not formally validated, it limits the strength of the recommendation we can formulate. Six trials compared MT with other intervention to another multimodal intervention or to a 340! placebo 3, 5, 11, 13, 23, 54 and results from these studies generally suggest that adding MT to a 341! multimodal intervention does not improve pain, function, or shoulder ROM. However, because 342! of the heterogeneous nature of the studies, we are unable to make formal conclusions on this 343! topic.
344! 345!
In our review, MT interventions were varied, and therefore, it could be argued that the effect 346! may differ depending on the technique used. A secondary analysis including only clinical trials 347! using joint (capsular) mobilisations and manipulations resulted in slightly different results than 348! those from our primary meta-analysis; suggesting that while a statistically significant effect was 349! observed, that effect may not be clinically important. MT interventions in the present review did 350! also vary in terms of intensity and duration. This is certainly a factor that may potentially affect 351! the overall expected treatment effect, but we could not account for this factor in our analyses 352! because the details of the MT interventions, for examples, intensity and duration, were in general 353! poorly described. Another factor that may limit the efficacy of MT is the clinical appropriateness 354! of techniques used. The use of MT may need to be tailored to specific impairments observed in 355! patients with RC tendinopathy. Two important subgroups of patients that may benefit the most 356! from mobilization and manipulation techniques are patients who have posteroinferior capsular 357! tightness of the glenohumeral joint or decreased cervicothoracic extension. Several studies 358! suggest that in these patients, shoulder kinematics are altered in a manner to promote RC 359! tendinopathy. 15, 18, 19, 22, 40, 51, 52 In the included studies, the type of MT intervention was not based 360! on the participants' impairments, therefore potentially limiting the overall treatment effect 361! observed. Future trials may want to take into account participants' impairment and tailor the MT 362! intervention accordingly. 363!
364!
Our conclusions are somewhat different from other published systematic reviews on the same 365! topic. 7, 8, 14, 16, 31, 38, 50 The 2 most recent systematic reviews on this topic stated that there were 366! inconclusive or conflicting results for the efficacy of MT used alone.
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